{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-016711","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.089127+00:00","generated_at":"2026-05-26T04:26:08.829467+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CytoSorbents raises $1.6M from Series A warrant exercises; total rights offering proceeds $7.85M","bullets":["1,417,208 Series A Right Warrants exercised at $1.13 each for $1.6M gross proceeds upon expiration.","Total rights offering gross proceeds reached $7.85M; net liquidity increased by ~$12.3M after restricted cash released.","Approximately 4.8M shares remain reserved for Series B Right Warrants, exercisable until April 10, 2025.","CEO notes progress on DrugSorb-ATR regulatory applications with U.S. FDA and Health Canada, expecting decisions in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-016711","json":"https://secwatch.observer/filing/0001104659-25-016711.json","markdown":"https://secwatch.observer/filing/0001104659-25-016711.md","text":"https://secwatch.observer/filing/0001104659-25-016711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925016711/0001104659-25-016711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925016711/tm257523d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:26:08.829467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}